Mia's Feed
Medical News & Research

Genetic Causes Identified for Severe Neuropathy Post-Infection

Genetic Causes Identified for Severe Neuropathy Post-Infection

Share this article

Recent genetic research has identified specific mutations responsible for a severe hereditary neuropathy triggered by infection, offering new avenues for diagnosis and potential treatment.

2 min read

Neuropathy, a condition characterized by nerve damage that can lead to impaired sensation and motor function, can arise from various causes, including infectious agents. Recent research from the UK has uncovered specific genetic mutations linked to a newly characterized form of neuropathy, offering insights into why some individuals develop severe nerve damage after infection while others remain unaffected.

Presented at the European Society of Human Genetics conference, Dr. Rob Harkness from the University of Manchester explained the case of a child who was healthy until seven months of age but suddenly became weak, floppy, and required respiratory support following a mild fever and rash. Tragically, the child died before turning one year old. Notably, two of her elder brothers exhibited similar symptoms. This prompted a genetic investigation which identified a mutation in a particular gene that was later found to be associated with the condition in multiple families worldwide.

The genetic changes identified in these patients produce symptoms resembling Guillain-Barré syndrome, an autoimmune neurological disorder often triggered by infections like Epstein-Barr virus or campylobacter bacteria. Guillain-Barré can cause rapid onset of weakness, starting in the legs and spreading through the body, impairing breathing in severe cases. The new genetic discovery suggests a similar pathway but rooted in inherited genetic variations.

Experimental studies on patient-derived cells revealed features similar to motor neuron disease (MND), hinting at shared mechanisms that could inform future treatments for both conditions. Although there are currently no specific therapies to prevent this form of neuropathy, understanding its genetic basis is a critical step toward developing targeted interventions.

This research also enhances diagnostic precision, enabling faster, more accurate identification of affected individuals. Such advancements mean that preconception genetic testing could become feasible, informing reproductive decisions and reducing the risk of transmitting the disorder.

As investigations continue, researchers are expanding their understanding by analyzing nerves derived from skin cells donated by affected patients and exploring models such as fruit flies. This research aims to elucidate how the identified gene influences nerve cells and why stress, temperature, and infection compromise nerve repair in this condition. The findings highlight a significant gene-environment interaction, emphasizing that genetic susceptibility combined with environmental triggers like infection can result in severe neuropathy.

Overall, this discovery marks a pivotal development in genetics and neurology, paving the way for improved diagnosis, prevention, and potentially, future treatments for hereditary neuropathies triggered by environmental factors.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Using Residential Locations to Predict Health Risks from Roach and Rodent Exposure

A groundbreaking study demonstrates how residential location data can predict children's exposure to pests like cockroaches and rodents, helping to better manage asthma and address health disparities associated with housing quality.

Urgent Need to Strengthen Canada's Oncology Workforce Amid Advanced Cancer Treatments

Canada faces the urgent need to expand and adapt its oncology workforce to meet the rising demands of advanced cancer treatments and improved survival rates. Experts highlight strategies for sustainable, high-quality cancer care amid ongoing advances.